Sermorelin, GHRP-6 10mg (Blend)

Sermorelin, GHRP-6 10mg (Blend) — Dual-Action Pituitary Growth Hormone Research Blend

This advanced 10mg synergistic formulation pairs Sermorelin with GHRP-6 (Growth Hormone Releasing Peptide-6) to create a robust, dual-mechanism architecture for neuroendocrine research. By combining a classic Growth Hormone-Releasing Hormone (GHRH) analogue with a potent Growth Hormone Secretagogue Receptor (GHSR) agonist, this blend allows investigators to explore amplified, pulsatile release pathways of endogenous growth hormone.

• Dual-Mechanism Pathway Synergy: Simultaneously targets distinct pituitary receptor configurations. Sermorelin binds to endogenous GHRH receptors, while GHRP-6 acts on the ghrelin/secretagogue receptors to suppress somatostatin, resulting in a significantly enhanced cellular signaling response.

• Key Research Areas: Widely utilized in metabolic, physiological, and gerontological studies to evaluate lean muscle tissue preservation, cellular repair dynamics, adipose metabolism, and the modulation of appetite signaling pathways.

• Purity Guaranteed: $\ge 99\%$ purity of each constituent peptide within the blend, verified by rigorous HPLC and Mass Spectrometry testing to maintain exact and repeatable experimental baselines.

• Optimal Stability: Supplied as a sterile, lyophilized powder format to protect structural peptide integrity and ensure precise reconstitution for in vitro and laboratory assays.

Note: This product is sold strictly as a high-purity research chemical. It is intended solely for laboratory, in vitro, or animal research applications and is not approved for human injection, therapeutic, or diagnostic use.